EMBL Logo
Travel and Contact  Staff Only  Site Map  Help?   
Research in Molecular Biology
EMBL Grenoble EMBL Hamburg EMBL heidelberg EMBL-EBI Hinxton EMBL Monterotondo
EMBLAbout UsScience and SocietyEMBL/EMBO Joint Conferences2004Abstracts
General Information
News and Communication
Today at EMBL
Events
Jobs
Alumni Association
Resource Development
Science and Society
EMBL/EMBO
Joint Conferences
2004
Programme
Invited Participants
Abstracts
Symposia
EMBL Forum Lectures
Discussion Meetings
Heidelberg Forum
Publications
PhD Symposium Writing Prize
Related Links
Advanced Training Centre Project
About Us Research Services Education
Image 1 Image 1 Audience
5th EMBL/EMBO Joint Conference 2004 Session III
Aging, industry and policies
The cosmetic point of view
Paolo Giacomoni, Executive Director-R&D, Clinique Laboratories, New York, USA

The reverse pyramid of ages in western populations has generated a market for products directed to accompany the aging baby-boomers. Besides geronto-medicine, a vast sector of consumers orient themselves towards nutritionals, sports, clothing, fashion, and cosmetics designed to meet the needs of the graying population. Skin aging is characterized by wrinkling, sagging, thinning and discoloration. The micro-inflammatory model of skin aging predicts the first three phenomena, and fails to predict the fourth one. Aging is defined as the accumulation of damages, and treatments able to reduce the rate of accumulation of damages can be thought of as anti-aging treatments. Strategies to avoid excessive exposure to solar ultraviolet radiation are but one example of successful treatments to slow down the rate of accumulation of damages in the skin and therefore to fight skin aging. Sunscreens are a tool used against ultraviolet radiation. The industry produces sunscreens designed and selected to be photo-stable with high molar extinction coefficients, non photo-toxic, non-allergising, odorless, and colorless. The alliance between industry and science has fostered great progress in photobiology. Legislation has set rules which differ in different parts of the globe: there are sunscreens accepted in the EU which are not allowed in the US, sunscreens accepted in the US which are forbidden in Europe. In Japan, the Ministry of Health requires that new products such as preservatives or sunscreens be tested on animals, whereas in Europe legislation imposes a ban on animal testing for cosmetics. Paradoxically, testing to assess safety in humans will have to be performed with alternative methods [i.e. not on animals] whereas new molecules will have to be tested on animals to be proven environmentally friendly. The cosmetic industry is complying with the regulatory requirements.
Last updated by: Halldór Stefánsson, 1 August 2007
EMBL Web Support